Xinyuan Lei

Ph.D. level scientist with hands-on experience in immunology-oncology

Research Expertise

Cancer Immunology
T cell Immunology
Immunology Oncology

About

Key words: Immunology oncology, Ph.D., Research Scientist, Flow cytometry, In vivo experiments, Translational research I'm a Ph.D. candidate trained in immunology and oncology. With 9+ years of research/teaching experience and 5+ years of clinical experience. I had 12 high-impact publications with 445+ citations, also 3 more publications in progress. I'm highly independent and scientifically critical with strong communication/writing skills (trilingual in English, Mandarin Chinese and Cantonese) and collaboration experience. Meanwhile, I took on roles of ad-hoc peer reviewer and editorial board member. Years of lab/clinic training, projects/people managing, troubleshooting and collaboration experience made me very confident of becoming a successful post-phd research scientist and a lifelong science explorer. • Project 1: Developed live-Listeria based, highly-attenuated, oral immunization cancer vaccine. Evaluating the immunogenicity and prophylactic/therapeutic efficacy of Lm vaccines in mice orthotopic colorectal cancer models. First author publication in review. • Project 2: Worked on how mitochondrial dynamics and ER stress regulating tumor antigen presentation and immunogenicity in solid tumors using pre-clinical models with a small molecule inhibitor. Published first author paper on Nature Communications (IF=16.6). PMCID: PMC9259736 • Project 3: Worked on combination of B7-H3 CAR-T therapy and epigenetic therapy to boost the anti-tumor efficacy. Published first author paper on Clinical Cancer Research (IF=13.8). PMCID: PMC8722110 • Project 4: Studying how retinoic acid signaling during T cell priming regulates intestinal CD103+ CD8 TRM cell formation. Published paper on Journal of Experimental Medicine (IF=17.6). PMCID: PMC9960115 • Others: Designed, Conducted, and Participated in projects related to anti PD-1/PD-L1 therapy, non-coding RNAs, cancer biology, molecular biology as an Assistant Mentor and Project Designer. Several publications. EB1a Green card holder. No sponsorship needed. Mobile number: +16312028917 Email: [email protected] I'm currently actively looking for a post-phd industry job with graduation time around February 2025. Please feel free to connect, message me if you're interested! I have a lot to offer! Let's make the world a better place together.

Publications

Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription

Cancer Research / Mar 15, 2019

Fan, S., Tian, T., Chen, W., Lv, X., Lei, X., Zhang, H., Sun, S., Cai, L., Pan, G., He, L., Ou, Z., Lin, X., Wang, X., Perez, M. F., Tu, Z., Ferrone, S., Tannous, B. A., & Li, J. (2019). Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription. Cancer Research, 79(6), 1069–1084. https://doi.org/10.1158/0008-5472.can-18-2505

Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing

Clinical Cancer Research / Jun 14, 2019

Tian, T., Lv, X., Pan, G., Lu, Y., Chen, W., He, W., Lei, X., Zhang, H., Liu, M., Sun, S., Ou, Z., Lin, X., Cai, L., He, L., Tu, Z., Wang, X., Tannous, B. A., Ferrone, S., Li, J., & Fan, S. (2019). Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing. Clinical Cancer Research, 25(12), 3673–3688. https://doi.org/10.1158/1078-0432.ccr-18-2739

Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation

Theranostics / Jan 01, 2019

Chen, W., Wang, P., Lu, Y., Jin, T., Lei, X., Liu, M., Zhuang, P., Liao, J., Lin, Z., Li, B., Peng, Y., Pan, G., Lv, X., Zhang, H., Ou, Z., Xie, S., Lin, X., Sun, S., Ferrone, S., … Fan, S. (2019). Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation. Theranostics, 9(20), 5739–5754. https://doi.org/10.7150/thno.37556

Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma

Biomedicine & Pharmacotherapy / Apr 01, 2019

Lu, Y., Li, Y., Wang, Z., Xie, S., Wang, Q., Lei, X., Ruan, Y., & Li, J. (2019). Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma. Biomedicine & Pharmacotherapy, 112, 108608. https://doi.org/10.1016/j.biopha.2019.108608

A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3–Specific CAR T Cells in Solid Tumors

Clinical Cancer Research / Apr 02, 2021

Lei, X., Ou, Z., Yang, Z., Zhong, J., Zhu, Y., Tian, J., Wu, J., Deng, H., Lin, X., Peng, Y., Li, B., He, L., Tu, Z., Chen, W., Li, Q., Liu, N., Zhang, H., Wang, Z., Fang, Z., … Fan, S. (2021). A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3–Specific CAR T Cells in Solid Tumors. Clinical Cancer Research, 27(13), 3757–3771. https://doi.org/10.1158/1078-0432.ccr-20-2487

LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis

Cell Death & Disease / Feb 01, 2021

Liu, M., Liu, Q., Fan, S., Su, F., Jiang, C., Cai, G., Wang, Y., Liao, G., Lei, X., Chen, W., Bi, J., Cheng, W., Zhao, L., Ruan, Y., & Li, J. (2021). LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis. Cell Death & Disease, 12(2). https://doi.org/10.1038/s41419-021-03415-2

Retinoic acid signaling during priming licenses intestinal CD103+ CD8 TRM cell differentiation

Journal of Experimental Medicine / Feb 21, 2023

Qiu, Z., Khairallah, C., Chu, T. H., Imperato, J. N., Lei, X., Romanov, G., Atakilit, A., Puddington, L., & Sheridan, B. S. (2023). Retinoic acid signaling during priming licenses intestinal CD103+ CD8 TRM cell differentiation. Journal of Experimental Medicine, 220(5). https://doi.org/10.1084/jem.20210923

Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression

Nature Communications / Jul 06, 2022

Lei, X., Lin, H., Wang, J., Ou, Z., Ruan, Y., Sadagopan, A., Chen, W., Xie, S., Chen, B., Li, Q., Wang, J., Lin, H., Zhu, X., Yuan, X., Tian, T., Lv, X., Fu, S., Zhu, X., Zhou, J., … Li, J. (2022). Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-31417-x

Identification of novel drug candidates for treating tongue squamous cell carcinoma using computational approaches

Feb 02, 2021

Li, Y., Chen, Z., Chen, L., & Li, W. (2021). Identification of novel drug candidates for treating tongue squamous cell carcinoma using computational approaches. https://doi.org/10.21203/rs.3.rs-177053/v1

1428-A Oral immunization withListeria-based cancer vaccines elicits protective gastrointestinal focused immunity in an orthotopic transplantation model of colorectal cancer

Regular Abstracts – Part 2 / Nov 01, 2023

Lei, X., Zhang, Y., Chuang, C., Chu, T., Garipcan, A., Qiu, Z., Li, X., Beyaz, S., & Sheridan, B. (2023). 1428-A Oral immunization withListeria-based cancer vaccines elicits protective gastrointestinal focused immunity in an orthotopic transplantation model of colorectal cancer. Regular Abstracts – Part 2, A1853–A1853. https://doi.org/10.1136/jitc-2023-sitc2023.1428-a

lncRNA CISAL Inhibits BRCA1 Transcription by Forming a Tertiary Structure at Its Promoter

iScience / Feb 01, 2020

Fan, S., Tian, T., Lv, X., Lei, X., Yang, Z., Liu, M., Liang, F., Li, S., Lin, X., Lin, Z., Xie, S., Li, B., Chen, W., Pan, G., Lin, X., Ou, Z., Zhang, Y., Peng, Y., Xiao, L., … Li, J. (2020). lncRNA CISAL Inhibits BRCA1 Transcription by Forming a Tertiary Structure at Its Promoter. IScience, 23(2), 100835. https://doi.org/10.1016/j.isci.2020.100835

Education

Stony Brook University

Ph.D. candidate, Microbiology and Immunology

Stony Brook

Sun Yat-sen Memorial Hospital

Master of Medicine, Oral and Maxillofacial Surgery / June, 2019

Guangzhou

Sun Yat-sen University

Bachelor of Medicine, Stomatology / June, 2016

Guangzhou

Experience

Stony Brook University

Research Assistant/Teaching Assistant / August, 2019Present

Links & Social Media

Join Xinyuan on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts